Course note
This course will begin running in spring 2027.
About this course
This course is designed to provide you with the opportunity to explore some of the most innovative topics in regenerative medicine, including cell therapy, cell-free therapies, and emerging technologies. You will gain insight into how research in these areas is conducted and how scientific discoveries translate into clinical practice. You’ll also learn about the latest advancements in the use of various cell types for therapy, the development of cell-free products, and the engineering and bioprinting technologies.
Throughout the course, you will have the chance to explore how laboratory research moves toward real-world applications, with a strong emphasis on patient safety, ethical considerations, and regulatory frameworks. By engaging with current research and case studies, you will broaden your understanding of the regenerative medicine field, a rapidly evolving field that incorporates innovative approaches.
Syllabus
Spring 2027 (Draft)
Go to syllabusThis is a draft syllabus. The final syllabus will be available here a few days prior to the new course’s first start date.
Pre-requisites
One year biology and one year chemistry at university level.
Faculty
Reza Yarani
FacultyPh.D (Cellular and Genetic Medicine, Department of Cellular and Molecular Biology, University of Copenhagen, 2016). Assistant Professor, Translational Type 1 Diabetes Research, Department of Clinical Research, Steno Diabetes Center Copenhagen, 2021-Present. With DIS since 2023.
